偏瘫型偏头痛的临床谱及发现致病突变的几率
本研究比较了208例携带CACNA1A、ATP1A2或SCN1A突变的家族性或散发性偏瘫型偏头痛患者与73例无这些基因突变的患者的临床特征,并对47例无已知基因突变的患者行全外显子测序。突变携带者发病年龄更低、受累家族成员更多,更常出现轻微头部外伤诱发发作、广泛运动无力及脑干症状、意识模糊和脑水肿,精神发育迟滞和进行性共济失调仅见于突变携带者。全外显子测序未发现新的致病基因。
要点
- 携带CACNA1A、ATP1A2或SCN1A突变的偏瘫型偏头痛患者发病年龄更低、受累家族成员更多。
- 突变携带者更常出现轻微头部外伤诱发发作、广泛运动无力及脑干症状、意识模糊和脑水肿。
- 无已知基因突变的偏瘫型偏头痛患者多表现为轻表型,更接近普通(非偏瘫型)偏头痛。
核心结论
- 无CACNA1A、ATP1A2或SCN1A突变的偏瘫型偏头痛患者大多表现为轻表型,更接近普通(非偏瘫型)偏头痛。
- 尚需发现偏瘫型偏头痛的第四个主要常染色体显性基因。
- 作者的观察可能有助于医生选择患者进行突变筛查并提供适当的遗传咨询。
研究设计与样本
- 比较208例携带CACNA1A、ATP1A2或SCN1A突变的家族性(n=199)或散发性(n=9)偏瘫型偏头痛患者与73例无这些基因突变的家族性(n=49)或散发性(n=24)患者的临床特征。
- 对47例无CACNA1A、ATP1A2或SCN1A突变的患者(家族性:n=33;散发性:n=14)行全外显子测序以筛查新基因突变。
主要发现
- 携带CACNA1A、ATP1A2或SCN1A突变的患者发病年龄更低、受累家族成员更多。
- 携带CACNA1A、ATP1A2或SCN1A突变的患者更常出现(1)轻微头部外伤诱发的发作、(2)广泛运动无力的发作、(3)伴脑干症状、意识模糊和脑水肿的发作。
- 精神发育迟滞和进行性共济失调仅见于携带突变的患者。
- 全外显子测序未能发现新基因中的致病突变。
临床怎么用
- 作者的观察可能有助于医生选择患者进行突变筛查并提供适当的遗传咨询。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether the clinical characteristics of patients with hemiplegic migraine with and without autosomal dominant mutations in CACNA1A, ATP1A2, or SCN1A differ, and whether the disease may be caused by mutations in other genes. METHODS: We compared the clinical characteristics of 208 patients with familial (n = 199) or sporadic (n = 9) hemiplegic migraine due to a mutation in CACNA1A, ATP1A2, or SCN1A with those of 73 patients with familial (n = 49) or sporadic (n = 24) hemiplegic migraine without a mutation in these genes. In addition, 47 patients (familial: n = 33; sporadic: n = 14) without mutations in CACNA1A, ATP1A2, or SCN1A were scanned for mutations in novel genes using whole exome sequencing. RESULTS: Patients with mutations in CACNA1A, ATP1A2, or SCN1A had a lower age at disease onset, larger numbers of affected family members, and more often attacks (1) triggered by mild head trauma, (2) with extensive motor weakness, and (3) with brainstem features, confusion, and brain edema. Mental retardation and progressive ataxia were exclusively found in patients with a mutation. Whole exome sequencing failed to identify pathogenic mutations in new genes. CONCLUSIONS: Most patients with hemiplegic migraine without a mutation in CACNA1A, ATP1A2, or SCN1A display a mild phenotype that is more akin to that of common (nonhemiplegic) migraine. A major fourth autosomal dominant gene for hemiplegic migraine remains to be identified. Our observations might guide physicians in selecting patients for mutation screening and in providing adequate genetic counseling.
引用
- Pelzer N, Haan J, Stam AH, et al. Clinical spectrum of hemiplegic migraine and chances of finding a pathogenic mutation. Neurology. 2018. PMID: 29343472. doi:10.1212/WNL.0000000000004966
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。